190 related articles for article (PubMed ID: 314938)
1. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. VI. Similar specificity patterns of protective anti-tumor immunity in vivo and of cytolytic T cells in vitro.
Bosslet K; Schirrmacher V; Shantz G
Int J Cancer; 1979 Sep; 24(3):303-13. PubMed ID: 314938
[No Abstract] [Full Text] [Related]
2. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. V. Transfer of protective immunity with H-2 identical immune T cells from B10.D2 mice.
Schirrmacher V
Int J Cancer; 1979 Jul; 24(1):80-6. PubMed ID: 314423
[No Abstract] [Full Text] [Related]
3. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. IV. Antigenic differences between a metastasizing variant and the parental tumor line revealed by cytotoxic T lymphocytes.
Schirrmacher V; Bosslet K; Shantz G; Clauer K; Hübsch D
Int J Cancer; 1979 Feb; 23(2):245-52. PubMed ID: 83969
[TBL] [Abstract][Full Text] [Related]
4. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. I. Tumor invasiveness in vitro and metastasis formation in vivo.
Schirrmacher V; Shantz G; Clauer K; Komitowski D; Zimmermann HP; Lohmann-Matthes ML
Int J Cancer; 1979 Feb; 23(2):233-44. PubMed ID: 761943
[No Abstract] [Full Text] [Related]
5. The specificity of effector T cells activated by tumours induced by murine oncornaviruses.
Shellam GR; Knight RA; Mitchison NA; Gorczynski RM; Maoz A
Transplant Rev; 1976; 29():249-76. PubMed ID: 58459
[No Abstract] [Full Text] [Related]
6. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
Weinhold KJ; Wheelock EF
Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity against tumour-associated antigens not H-2 restricted.
Holden HT; Herberman RB
Nature; 1977 Jul; 268(5617):250-2. PubMed ID: 69992
[No Abstract] [Full Text] [Related]
8. Tumor immunity to murine plasma cell tumors. III. Detection of common and unique tumor-associated antigens on BALB/c, C3H, and NZB plasmacytomas by in vivo and in vitro induction of tumor-immune responses.
Burton RC; Warner NL
J Natl Cancer Inst; 1977 Mar; 58(3):701-9. PubMed ID: 300112
[TBL] [Abstract][Full Text] [Related]
9. Characterization to effector lymphocytes associated with immunity to murine sarcoma virus (MSV)-induced tumors. II. Repeated stimulation and proliferation in vitro of specific cytolytic T lymphocytes.
Plata F; Jongeneel CV
J Immunol; 1977 Aug; 119(2):623-9. PubMed ID: 196025
[No Abstract] [Full Text] [Related]
10. Cell-mediated cytotoxic reactions to tumor associated antigens.
Herberman RB
J Reticuloendothel Soc; 1975 Apr; 17(4):236-40. PubMed ID: 50447
[No Abstract] [Full Text] [Related]
11. Inhibition of T-lymphocyte-mediated tumor-specific lysis by alloantisera directed against the H-2 serological specificities of the tumor.
Germain RN; Dorf ME; Benacerraf B
J Exp Med; 1975 Oct; 142(4):1023-8. PubMed ID: 809532
[TBL] [Abstract][Full Text] [Related]
12. Antigenic changes of DBA/2J mastocytoma cells when grown in the BALB/c mouse.
Wolf JE; Faanes RB; Choi YS
J Natl Cancer Inst; 1977 May; 58(5):1407-12. PubMed ID: 67213
[TBL] [Abstract][Full Text] [Related]
13. In vivo studies of the role of cytotoxic T cells in tumor allograft immunity.
Freedman LR; Cerottini JC; Brunner KT
J Immunol; 1972 Dec; 109(6):1371-8. PubMed ID: 4538966
[No Abstract] [Full Text] [Related]
14. The cell-mediated immune response: interactions of initiator and recruited T lymphocytes.
Cohen IR; Livnat S
Transplant Rev; 1976; 29():24-58. PubMed ID: 5792
[No Abstract] [Full Text] [Related]
15. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
Sensi ML; Parenza M; Parmiani G
J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938
[TBL] [Abstract][Full Text] [Related]
16. Thymus derived killer cells: specificity of function, and antigen recognition.
Dennert G
Transplant Rev; 1976; 29():59-88. PubMed ID: 58462
[No Abstract] [Full Text] [Related]
17. Cell-mediated immunity in vitro against syngeneic mouse plasma tumour cells.
Wagner H; Röllinghoff M
Nat New Biol; 1973 Jan; 241(106):53-4. PubMed ID: 4540590
[No Abstract] [Full Text] [Related]
18. Tumor immunity to murine plasma cell tumours. Influence of responder genotype on the specificity of the immune response to plasmacytomas and T lymphomas.
Burton RC; Warner NL
Aust J Exp Biol Med Sci; 1978 Oct; 56(5):587-95. PubMed ID: 751633
[TBL] [Abstract][Full Text] [Related]
19. F1 resistance to AKR lymphoma cells in vivo and in vitro.
Schmitt-Verhulst A-M ; Zatz MM
J Immunol; 1977 Jan; 118(1):330-3. PubMed ID: 830755
[TBL] [Abstract][Full Text] [Related]
20. Specificity of cell-mediated transplantation reactions. I. Studies with the technique of inhibition of migration and an assay of tumour immunity in vivo.
Lake P; Sabbadini E; Sehon AH
Immunology; 1974 Sep; 27(3):427-39. PubMed ID: 4137936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]